Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 42 min ago
PreprintCC BY-NC-NDbioRxiv

RhoA effectors ROCK and SLK/LOK oppositely regulate VE-cadherin mobility at endothelial junctions

Abstract

Cellular contractile forces regulate VE-cadherin dynamics, adhesion, and endothelial junction integrity. RhoA controls these forces through two parallel effector kinases: ROCK, which activates non-muscle myosin II motors, and SLK/LOK, which promote actin-membrane attachment through phosphorylation of ezrin, radixin, moesin proteins (ERM). How these two RhoA effector pathways differentially affect VE-cadherin dynamics at junctions is not known. Using single-molecule tracking of Halo-tagged VE-cadherin, we obtained a detailed characterization of VE-cadherin diffusive behavior inside and outside junctional regions in cultured human umbilical vein endothelial cells (HUVEC). VE-cadherin was substantially less mobile and more confined within junctions than in non-junctional membrane. Inhibiting ROCK with Y-27632 increased VE-cadherin mobility both inside and outside junctions, consistent with RhoA/ROCK-driven contractility restraining cadherin diffusion globally. Unexpectedly, inhibiting SLK/LOK produced the opposite effect, selectively reducing VE-cadherin mobility within junctions with no comparable change outside them. This effect was accompanied by an increase in reticular junctions, suggesting that SLK/LOK inhibition alters VE-cadherin mobility indirectly, through a change in junctional architecture, rather than through a direct effect of actin-membrane coupling on VE-cadherin itself. These findings identify SLK/LOK as a regulator of VE-cadherin dynamics acting in parallel to ROCK downstream of RhoA and point to junctional architecture as a previously unappreciated determinant of VE-cadherin mobility at endothelial cell-cell contacts.

Related

  1. Adipocyte Kindlin-2 Coordinates an E-cadherin/β-catenin/IGFBP2 Endocrine Axis to Regulate Skin Regeneration and Diabetic Wound Healing
    Z. Ding, G. Ma, F. Wang +8
    bioRxivPreprintCC BY-NDFull textMolecular biology & gene regulationbioRxiv
  2. Nuclear SUN2 coordinates endothelial cell-matrix interactions to regulate blood vessel homeostasis and barrier function.
    Pauline Bougaran, Danielle B Buglak, Alexandra Neal +11
    AngiogenesisPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMC
  3. Minimal indel-inducing and window-adjustable base editing using inactive Cas12b effectors
    Wi-jae Lee, Yun Gyeong Kim, Yeounsun Oh +5
    Molecular therapy. Nucleic acidsPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMC
  4. Bacterial effectors targeting the host ubiquitin system
    Paula Eschger, Thomas Hermanns, Kay Hofmann
    Biochemical Society TransactionsPeer-reviewedCC BY 4.0Full textEnzymology & metabolismMicrobiologyPMC
  5. Translational isoforms of mammalian heterochromatin protein 1 (HP1) tune its interactions with chromatin effectors
    E. M. Smith, E. Khalizeva, S. Haug +1
    bioRxivPreprintCC BY-NCFull textMolecular biology & gene regulationbioRxiv
BibTeX
@misc{nelson2026rhoa,
  title = {{RhoA effectors ROCK and SLK/LOK oppositely regulate VE-cadherin mobility at endothelial junctions}},
  author = {Tyler Nelson and Qiyao Lin and Zoya Quddoos and Henry Gatica-Gutierrez and Sofia Vargas-Hernandez and Arnold Hayer and Anna-Karin Gustavsson},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.28.762575},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.28.762575v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - RhoA effectors ROCK and SLK/LOK oppositely regulate VE-cadherin mobility at endothelial junctions
AU  - Tyler Nelson
AU  - Qiyao Lin
AU  - Zoya Quddoos
AU  - Henry Gatica-Gutierrez
AU  - Sofia Vargas-Hernandez
AU  - Arnold Hayer
AU  - Anna-Karin Gustavsson
PY  - 2026
DA  - 2026/10/28
PB  - bioRxiv
DO  - 10.64898/2026.10.28.762575
UR  - https://www.biorxiv.org/content/10.64898/2026.10.28.762575v1
AB  - Cellular contractile forces regulate VE-cadherin dynamics, adhesion, and endothelial junction integrity. RhoA controls these forces through two parallel effector kinases: ROCK, which activates non-muscle myosin II motors, and SLK/LOK, which promote actin-membrane attachment through phosphorylation of ezrin, radixin, moesin proteins (ERM). How these two RhoA effector pathways differentially affect VE-cadherin dynamics at junctions is not known. Using single-molecule tracking of Halo-tagged VE-cadherin, we obtained a detailed characterization of VE-cadherin diffusive behavior inside and outside junctional regions in cultured human umbilical vein endothelial cells (HUVEC). VE-cadherin was substantially less mobile and more confined within junctions than in non-junctional membrane. Inhibiting ROCK with Y-27632 increased VE-cadherin mobility both inside and outside junctions, consistent with RhoA/ROCK-driven contractility restraining cadherin diffusion globally. Unexpectedly, inhibiting SLK/LOK produced the opposite effect, selectively reducing VE-cadherin mobility within junctions with no comparable change outside them. This effect was accompanied by an increase in reticular junctions, suggesting that SLK/LOK inhibition alters VE-cadherin mobility indirectly, through a change in junctional architecture, rather than through a direct effect of actin-membrane coupling on VE-cadherin itself. These findings identify SLK/LOK as a regulator of VE-cadherin dynamics acting in parallel to ROCK downstream of RhoA and point to junctional architecture as a previously unappreciated determinant of VE-cadherin mobility at endothelial cell-cell contacts.
SN  - 2692-8205
ER  -